---
$id: https://graph.org.ai/products/commodity/51171981
$type: Product
source: UNSPSC
code: "51171981"
title: "Carbenoxolone"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carbenoxolone

**UNSPSC Code**: 51171981
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hydroxysteroid dehydrogenase inhibitor with the molecular formula C34H50O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MM6384NG73, chemically known as olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-, hydrogen succinate but generally known as carbenoxolone, which bears US NIH Compound Identifier 21913. Carbenoxolone comes in base, adrenochrome, and sodium forms. European Medicines Agency schedules Carbenoxolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06123MIG. The term CARBENOXOLONE is an International Non-Proprietary Name. World Health Organization schedules carbenoxolone in its Anatomical Therapeutic Chemical (ATC) Classification. CARBENOXOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CARBENOXOLONE remains the US FDA Preferred Term for this commodity. Carbenoxolone bears US NLM identifiers UMLS ID C0006979 and NCI Concept Code C63669. SMILES: O(C1C(C2C(C3C(C4(C(=CC3=O)C3C(CC4)(CCC(C3)(C)C(=O)O)C)C)(CC2)C)(CC1)C)(C)C)C(=O)CCC(=O)O.

